Vaccine News and Research

Latest Vaccine News and Research

Econiche vaccine cited in February, 2010 issue of Scientific American

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced that Econiche(TM), the world's first vaccine developed to reduce the shedding by cattle of Escherichia coli (E. coli) O157, has been cited in the February, 2010 issue of Scientific American (Vol. 302, # 2).

29 Jan 2010

Diabetes vaccine: Diamyd Medical to file for market approval in 2011

In her comments in today’s quarterly report Elisabeth Lindner, President and CEO of Diamyd Medical, says that the Company’s objective is to file the Diamyd® diabetes vaccine for market approval in 2011 - a goal that isn’t very far off now.

29 Jan 2010

Experimental vaccine protects mice and monkeys against chikungunya virus

An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found.

29 Jan 2010

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

In an acute viral infection, most of the white blood cells known as T cells differentiate into cells that fight the virus and die off in the process. But a few of these "effector" T cells survive and become memory T cells, ensuring that the immune system can respond faster and stronger the next time around.

29 Jan 2010

Mandatory influenza vaccination policy improves immunization rates among health care workers

A mandatory influenza vaccination policy improves immunization rates among health care workers, according to a recent study of a large health care organization.

29 Jan 2010

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

Watson Pharmaceuticals, Inc. today announced that it has completed the acquisition of Eden Biopharm Group Limited for approximately $15 million. Eden is a biopharmaceutical development and contract manufacturing company located in Liverpool, UK. As a result of the acquisition of the Arrow Group in December 2009, Watson had previously acquired approximately 36 percent of Eden.

29 Jan 2010

Rotavirus vaccine could save millions of children in developing countries, studies find

Efforts to vaccinate "infants against rotavirus could save the lives of millions of children in developing nations who would otherwise die from the diarrhea-causing disease, two new studies show," HealthDay/BusinsessWeek reports.

28 Jan 2010

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

Idera Pharmaceuticals, Inc. today announced initiation of a Phase 1 clinical trial of IMO-3100, an antagonist of Toll-like Receptor (TLR) 7 and TLR9.

28 Jan 2010

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

In tonight's State of the Union Address President Obama failed to announce any new approach to America's role in the world, instead sticking to vague rhetoric about development, the global HIV/AIDS crisis, and other global health priorities.

28 Jan 2010

Baxter International reports net income of $572M for the fourth-quarter of 2009

Baxter International Inc. today reported strong performance for the fourth quarter of 2009, and provided its financial outlook for the first quarter and full-year 2010.

From Baxter International Inc. 28 Jan 2010

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

For the first time ever, studies in Mexico and Africa, published today in the New England Journal of Medicine, demonstrate a reduction in diarrheal disease deaths following rotavirus vaccine introduction in Mexico and vaccine efficacy among impoverished populations in Malawi and South Africa.

28 Jan 2010

Blocking action of key protein boosts immune 'memory' to prevent or clear viral infection

Researchers at The Scripps Research Institute have discovered a potential new way to stimulate the immune system to prevent or clear a viral infection. By blocking the action of a key protein in the mouse immune system, they were able to boost immune "memory" in those mice-work that may one day help doctors increase the effectiveness of human vaccines designed to prevent viral infections.

28 Jan 2010

Formatech donates $308K in aseptic liquid fill and finish manufacturing services

Formatech continues its pledge to give back and make a difference in the biotechnology and pharmaceutical community with its Fillanthropy Program. Since the program’s inception, Formatech has donated $308K in aseptic liquid fill and finish manufacturing services to companies developing new drug therapies.

28 Jan 2010

Blocking CRF may prevent excessive alcohol consumption

A team of scientists from The Scripps Research Institute has found that a specific stress hormone, the corticotropin-releasing factor (CRF), is key to the development and maintenance of alcohol dependence in animal models.

28 Jan 2010

Pfizer's new pipeline shows growth and diversity in research and development

Pfizer Inc. today provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets from both legacy companies, includes 133 programs from phase 1 through registration, and shows growth and increased diversity in each of the areas where the company invests in research and development.

28 Jan 2010

Sinovac prices public offering at $5.75 per common share

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today that it has priced its public offering of 10,000,000 common shares at $5.75 per common share. Sinovac has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,500,000 common shares on the same terms and conditions.

28 Jan 2010

Inovio Biomedical unveils new clinical-grade, miniaturized electroporation device

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, today unveiled its new clinical-grade, miniaturized electroporation device designed to be an easy-to-use, portable delivery product for DNA vaccines.

28 Jan 2010

NIH to perform exploratory studies on ImmuneRegen BioSciences' Homspera

ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.

28 Jan 2010

NewsRx publishes new encyclopedia on vaccines

NewsRx, a 25-year-old publisher and international news organization headquartered in Atlanta, has published a new encyclopedia on vaccines -- Encyclopedia of Vaccines, 2009: An encyK Resource for Parents, Patients & Professionals.

28 Jan 2010

Canada to 'champion' major G8 initiative to tackle maternal, child mortality

As president of the G8 in 2010, "Canada will champion a new G8 identity focused on ending child mortality and other health woes in poorer countries when it hosts the club of industrialized nations in June, the government said Tuesday," Agence France-Presse reports. A spokesman for Canadian Prime Minister Stephen Harper explained Tuesday that Harper will use his keynote address at the World Economic Forum annual meeting in Davos, Switzerland, to provide more details about the new G8 agenda, according to AFP (1/26).

28 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

Econiche vaccine cited in February, 2010 issue of Scientific American

Diabetes vaccine: Diamyd Medical to file for market approval in 2011

Experimental vaccine protects mice and monkeys against chikungunya virus

Findings could guide in developing more effective vaccines for HIV/AIDS and cancer

Mandatory influenza vaccination policy improves immunization rates among health care workers

Watson Pharmaceuticals acquires Eden Biopharm Group for approximately $15M

Rotavirus vaccine could save millions of children in developing countries, studies find

Idera Pharmaceuticals commences IMO-3100 Phase 1 clinical trial for autoimmune diseases

Obama fails to announce new approaches for tackling global HIV/AIDS crisis, says Global AIDS Alliance

Baxter International reports net income of $572M for the fourth-quarter of 2009

Studies in Mexico and Africa demonstrate the effectiveness of rotavirus vaccine

Blocking action of key protein boosts immune 'memory' to prevent or clear viral infection

Formatech donates $308K in aseptic liquid fill and finish manufacturing services

Blocking CRF may prevent excessive alcohol consumption

Pfizer's new pipeline shows growth and diversity in research and development

Sinovac prices public offering at $5.75 per common share

Inovio Biomedical unveils new clinical-grade, miniaturized electroporation device

NIH to perform exploratory studies on ImmuneRegen BioSciences' Homspera

NewsRx publishes new encyclopedia on vaccines

Canada to 'champion' major G8 initiative to tackle maternal, child mortality

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vaccine News and Research

Latest Vaccine News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in